glutamic acid has been researched along with levetiracetam in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brodie, MJ; Forrest, G; Fraser, CM; Leach, JP; Patsalos, PN; Sills, GJ | 1 |
| Aldenkamp, AP; Bootsma, HP; Kessels, AG; Leenen, LA; Leonard, BE; Majoie, HJ; Roberts, GM | 1 |
| Jensen, JE; Kaufman, RE; Pollack, MH; Renshaw, PF; Simon, NM | 1 |
| Kaminski, RM; Klitgaard, H; Matagne, A; Patsalos, PN | 1 |
| Chen, CC; Lee, CY; Liou, HH | 1 |
| Dehmel, T; Kieseier, BC; Köhne, A; Mausberg, AK; Rose, CR; Stettner, M | 1 |
| Biber, B; Björklund, U; Block, L; Hansson, E; Jörneberg, P; Westerlund, A | 1 |
| Lipton, SA; McKercher, SR; Piña-Crespo, JC; Sanz-Blasco, S; Zhang, X | 1 |
| Akinyemi, A; Michel, G; Sanchez-Gonzalez, MA; Sterkel, S | 1 |
| Brigo, F; Nardone, R; Tezzon, F | 1 |
| Borisova, T; Pastukhov, A | 1 |
| Fukuyama, K; Okada, M | 1 |
1 review(s) available for glutamic acid and levetiracetam
| Article | Year |
|---|---|
Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Epilepsy; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam | 2009 |
2 trial(s) available for glutamic acid and levetiracetam
| Article | Year |
|---|---|
Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam.
Topics: Adult; Anticonvulsants; Chi-Square Distribution; Demography; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Fructose; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Levetiracetam; Male; Middle Aged; Models, Biological; Mood Disorders; Odds Ratio; Piracetam; Time Factors; Topiramate | 2005 |
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Levetiracetam; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nootropic Agents; Piracetam | 2008 |
10 other study(ies) available for glutamic acid and levetiracetam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.
Topics: 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Brain; Drug Administration Schedule; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Glutamine; Levetiracetam; Male; Mice; Mice, Inbred ICR; Piracetam | 1997 |
Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.
Topics: Animals; Anticonvulsants; Calcium Channels, P-Type; Calcium Channels, Q-Type; Dentate Gyrus; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Levetiracetam; Male; Patch-Clamp Techniques; Piracetam; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2009 |
Levetiracetam exhibits protective properties on rat Schwann cells in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blotting, Western; Cells, Cultured; Glutamic Acid; In Vitro Techniques; Levetiracetam; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neuroprotective Agents; Oxidative Stress; Piracetam; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Schwann Cells | 2011 |
A new concept affecting restoration of inflammation-reactive astrocytes.
Topics: Actins; Analgesics, Opioid; Animals; Astrocytes; Calcium Signaling; Capillaries; Coculture Techniques; Cytokines; Cytoskeleton; Endothelial Cells; Glutamic Acid; Inflammation; Interleukin-1beta; Levetiracetam; Lipopolysaccharides; Male; Naloxone; Narcotic Antagonists; Nootropic Agents; Oligopeptides; Piracetam; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2013 |
Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes.
Topics: Amyloid beta-Peptides; Astrocytes; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Glutamic Acid; HEK293 Cells; Humans; Levetiracetam; Luminescent Proteins; Microscopy, Fluorescence; Nootropic Agents; Peptide Fragments; Piracetam; Transfection | 2016 |
Preserving brain function in a comatose patient with septic hyperpyrexia (41.6 °C): a case report.
Topics: Adult; Amantadine; Anticonvulsants; Brain; Brain Injuries; Cognition Disorders; Coma; Dopamine Agents; Drug Therapy, Combination; Glutamic Acid; Humans; Levetiracetam; Male; Malignant Hyperthermia; Piracetam; Tomography, X-Ray Computed | 2017 |
Forced normalization and antiepileptic drugs interacting with glutamatergic neurotransmission: Caution is needed.
Topics: Adult; Anticonvulsants; Drug Resistant Epilepsy; Electroencephalography; Female; Glutamic Acid; Humans; Levetiracetam; Nitriles; Psychoses, Substance-Induced; Pyridones; Synaptic Transmission; Topiramate; Zonisamide | 2017 |
Levetiracetam-mediated improvement of decreased NMDA-induced glutamate release from nerve terminals during hypothermia.
Topics: Animals; Brain; Glutamic Acid; Hypothermia; Levetiracetam; Male; Membrane Potentials; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Synaptosomes; Trans-Activators | 2018 |
Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein.
Topics: Animals; Anticonvulsants; Astrocytes; Connexin 43; Glutamic Acid; Levetiracetam; Pyrrolidinones; Rats; Synaptic Vesicles | 2022 |